Your browser doesn't support javascript.
loading
Characteristics of Real-World Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab and Pembrolizumab During the Year Following Approval.
Khozin, Sean; Abernethy, Amy P; Nussbaum, Nathan C; Zhi, Jizu; Curtis, Melissa D; Tucker, Melisa; Lee, Shannon E; Light, David E; Gossai, Anala; Sorg, Rachael A; Torres, Aracelis Z; Patel, Payal; Blumenthal, Gideon Michael; Pazdur, Richard.
Affiliation
  • Khozin S; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Abernethy AP; Flatiron Health, New York, New York, USA amy@flatiron.com.
  • Nussbaum NC; Flatiron Health, New York, New York, USA.
  • Zhi J; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Curtis MD; Flatiron Health, New York, New York, USA.
  • Tucker M; Flatiron Health, New York, New York, USA.
  • Lee SE; Flatiron Health, New York, New York, USA.
  • Light DE; Flatiron Health, New York, New York, USA.
  • Gossai A; Flatiron Health, New York, New York, USA.
  • Sorg RA; Flatiron Health, New York, New York, USA.
  • Torres AZ; Flatiron Health, New York, New York, USA.
  • Patel P; Flatiron Health, New York, New York, USA.
  • Blumenthal GM; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
  • Pazdur R; U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Oncologist ; 23(3): 328-336, 2018 03.
Article de En | MEDLINE | ID: mdl-29317551

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Anticorps monoclonaux humanisés / Antinéoplasiques immunologiques / Nivolumab / Tumeurs du poumon Type d'étude: Clinical_trials / Prognostic_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Oncologist Sujet du journal: NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome pulmonaire non à petites cellules / Anticorps monoclonaux humanisés / Antinéoplasiques immunologiques / Nivolumab / Tumeurs du poumon Type d'étude: Clinical_trials / Prognostic_studies Limites: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Oncologist Sujet du journal: NEOPLASIAS Année: 2018 Type de document: Article Pays d'affiliation: États-Unis d'Amérique